Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review

Author(s):: Arts-de Jong, M.; Bock, G.H. de; Asperen, C.J. van (0000-0002-1436-7650); Mourits, M.J.E.; Hullu, J.A. de; Kets, C.M.

Published: 2016
Publication type: Article / Letter to editor

ProbabilityEpithelial ovarian cancerBRCA mutationGenetic testingReferral

Date issued: 2016-07-31
Language: English
Is part of: European Journal of Cancer (2016), Vol. 61, p. 137-145
hdl: 1887/112990
doi: 10.1016/j.ejca.2016.03.009